Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Investigate the Safety and Efficacy of Two Concentrations of DE-110 Compared to Placebo for the Treatment of Dry Eye Disease
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| DE-110 ophthalmic suspension high dose | Experimental |
| |
| DE-110 ophthalmic suspension low dose | Experimental |
| |
| Placebo | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| DE-110 ophthalmic suspension high dose | Drug | ophthalmic suspension; high dose; QID |
|
| Measure | Description | Time Frame |
|---|---|---|
| Efficacy of DE-110 | 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Individual Response Rate | 12 weeks | |
| Individual Efficacy | 12 weeks | |
| Individual Symptoms |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Inglewood | California | United States | ||||
| Type | Date | Date Unknown |
|---|---|---|
| Release | Apr 14, 2017 | |
| Reset | May 19, 2017 |
Not provided
Not provided
Not provided
Not provided
Not provided
| DE-110 ophthalmic suspension low dose | Drug | ophthalmic suspension; low dose; QID |
|
| Placebo | Other | DE-110 ophthalmic suspension vehicle;QID |
|
| 12 weeks |
| Newport Beach |
| California |
| United States |
| Petaluma | California | United States |
| Torrance | California | United States |
| Bloomfield | Connecticut | United States |
| Bradenton | Florida | United States |
| Brooksville | Florida | United States |
| Largo | Florida | United States |
| Rosewell | Georgia | United States |
| Louisville | Kentucky | United States |
| Bangor | Maine | United States |
| Cleveland | Ohio | United States |
| San Antonio | Texas | United States |
| Norfolk | Virginia | United States |
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Apr 14, 2017 | May 19, 2017 |
| ID | Term |
|---|---|
| D015352 | Dry Eye Syndromes |
| ID | Term |
|---|---|
| D007766 | Lacrimal Apparatus Diseases |
| D005128 | Eye Diseases |
Not provided
Not provided